M&A activity and market drivers
The M&A market in healthcare across Europe remains extremely vibrant, with global investors attracted by well-entrenched multiples and the potential to create pan-European offerings in specific sectors.
Read moreThe M&A market in healthcare across Europe remains extremely vibrant, with global investors attracted by well-entrenched multiples and the potential to create pan-European offerings in specific sectors.
Read moreLeading players are turning to consolidation to access technology and global markets in order to maintain their competitive edge.
Read moreThe residential care home market continues to see growth because of the ageing population whilst real estate investment trusts (REITs) are increasingly moving into healthcare markets, such as specialist care.
Read moreThe global animal health market, which includes commercial animal and companion animal products, is experiencing significant growth driven by increasing demand for commercial animal vaccines (to mitigate the risk of disease in livestock) and a significant increase in pet ownership.
Read moreLarge pharma companies are under pressure from investors due to rising competition from generics and eroding top-line figures. Over the past year some 60% of deals in the pharma segment have been focused on boosting drug pipelines of large pharma companies.
Read more